medigraphic.com
ISSN 0016-3813 (Impreso)

2007, Número 3

<< Anterior Siguiente >>

Gac Med Mex 2007; 143 (3)


Manejo del hematoma subdural crónico mediante minitrépano y sistema de drenaje sin succión, experiencia en 213 pacientes

Santos-Ditto RA, Santos-Franco JA, Pinos-Gavilanes MW, Mora-Benítez H, Saavedra T, Martínez-Gonzáles V, Volkow-Fernández P

Idioma: Español
Referencias bibliográficas: 43
Paginas: 209-214
Archivo PDF: 58.88 Kb.


RESUMEN

Introducción: Un subgrupo de pacientes con carcinoma epidermoide cutáneo (CEC) tiene alto riesgo de presentar metástasis ganglionares regionales. El mapeo linfático y biopsia del ganglio centinela (MLBGC) ha sido exitosamente utilizado para evaluar la presencia de metástasis ganglionares subclínicas en diversos tumores.
Objetivo: Evaluar la utilidad de la técnica del MLBGC en los pacientes con CEC de alto riesgo para detectar la presencia de metástasis ganglionares regionales subclínicas.
Material y métodos: De enero 2002 a marzo 2004, un total de 20 pacientes con CEC de alto riesgo con ganglios linfáticos regionales clínicamente no palpables fue evaluado con linfografía preoperatoria y MLBGC.
Resultados: En 1 de cada 5 pacientes (20 %), el ganglio centinela reveló la presencia de micrometástasis. Ningún paciente con GC negativo manifestó progresión tumoral ganglionar regional durante un seguimiento medio de 23.5 meses (rango de 7 a 44 meses).
Conclusiones: El MLBGC fue técnicamente posible con baja morbilidad. El MLBGC puede tener un importante papel en el tratamiento de los pacientes con CEC de alto riesgo con ganglios linfáticos regionales no palpables. Esta técnica puede ayudar a identificar los pacientes con metástasis en los ganglios linfáticos regionales que pueden beneficiarse de una disección ganglionar radical. Además provee importante información para utilizar terapias adyuvantes a la cirugía.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kwa R, Campana K, Moy R. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992;26:1-4.

  2. Gómez F, Reséndiz J, Rodríguez S. Cáncer de piel. En: Rodríguez S. Tumores de Cabeza y Cuello. Manual Moderno 2003:269-310.

  3. Gloster H, Brodland D. The epidemiology of skin cancer. Dermatol Surg 1996;22:217-226.

  4. Gallagher R, Ma B, McLean D, Yang CP, Ho V, Carruthers JA, et al. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol 1990;23:413-421.

  5. Marks R. An overview of skin cancers. Incidence and causation. Cancer 1995;75:607-612.

  6. Glass A, Hoover R. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 1989;262:2097-2100.

  7. Schoelch S, Barret T, Grenway H. Advances in military dermatology. Dermatol Clin 1999;17:93-111.

  8. Epstein E, Epstein N, Bragg K, Linden G. Metastases from squamous cell carcinoma of the skin. Arch Dermatol 1968;97:248-251.

  9. Rowe D, Carroll R, Day C. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol 1992;26:976-990.

  10. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Plast Surg 2003;56:85-91.

  11. Weisberg N, Bertagnolli M, Becker D. Combined sentinel lymphadenectomy and Mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2000;43:483-488.

  12. Chu A, Osguthortpe D. Nonmelanoma cutaneous malignancy with regional metastasis. Otolaryngol Head Neck Surg 2003; 128:663-673.

  13. Reschly M, Messina J, Zaulyanov L, Cruse W, Fenske NA. Utility of sentinel limphadenectomy in the management of patients whit high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2003; 29:135-140.

  14. Wagner J, Evdokinow D, Weisberg E, Moore D, Chuang TY, Wenck S, et al. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol 2004; 140:75-79.

  15. Baker N, Webb A, Macpherson D. Surgical management of cutaneous squamous cell carcinoma of the head and neck. Br J Oral Maxillofac Surg 2001;39:87-90.

  16. Jol JA, van Velthuysen M, Hilgers F, Keus RB, Neering H, Balm AJ. Treatment results of regional metastasis from cutaneous head and neck squamous cell carcinoma. Eur J Surg Oncol 2002;29:81-86.

  17. Khanna M. Reporting tumor thickness for cutaneous squamous cell carcinoma. J Cutan Pathol 2002; 29:321-323.

  18. Petter G, Haustein U. Squamous cell carcinoma of the skin – histopathological features and their significance for the clinical outcome. J Eur Acad Dermatol Venereol 1998;11:37-44.

  19. Friedman H, Cooper P, Wanebo H. Prognostic and therapeutic use of microstaging in cutaneous squamous cell carcinoma of the trunk and extremities. Cancer 1985; 56:1099-1105.

  20. Breuninger H, Black B, Rassner G. Microstaging of squamous cell carcinoma. Am J Pathol 1990; 94:624-625.

  21. Breuninger H, Schaumburg-Lever G, Holzschuh J. Desmoplastic squamous cell carcinoma of the skin and vermellion surface. Cancer 1997;79:915-918.

  22. Broders A. Squamous cell epithelioma of the lip. JAMA 1920; 74:654-666.

  23. Mendenhall W, Parsons J, Mendenhall N, Stringer SP, Cassisi NJ, Watson R, et al. Carcinoma of the skin of the head and neck with perineural invasion. Head Neck 1989; 11:301-308.

  24. Cottel W. Perineural invasion by squamous cell carcinoma. J Dermatol Surg Oncol 1982;8:589-600.

  25. Veness M, Morgan G, Palme C, Gebski V. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: Combined treatment should be considered best practice. Laryngoscope 2005; 115:870-875.

  26. Brown R, Osguthortpe J. Management of the neck in nonmelanocytic cutaneous carcinomas. Otolaryngol Clin N Am 1998;31:844-851.

  27. Morton D, Wen D, Wong J, Turner R, Essner R, Wanek S, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.

  28. Albertini J, Lyman G, Cox C, Chuang T, Wenck S, Ho Y, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-1822.

  29. Fowler J. Sentinel lymph node biopsy for staging penile cancer. Urology 1984;23:352-354.

  30. De Hullu J, Holeman H, Piers D, Chalian A, Weinstein G, Weber R, et al. Sentinel lymph node dissection is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000;18:2811-2816.

  31. Hill A, Brady M, Coit D. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg 1999;86:518-521.

  32. Johnson T, Rowe D, Nelson B, Mentis D, Hurst T, Stevens G, et al. Squamous cell carcinoma of the skin excluding lip and oral mucosa. J Am Acad Dermatol 1992;26:467-484.

  33. Cherpelis B, Marcusen C, Lang P. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 2002;28:268-273.

  34. Morton D, Cochran A, Thompson J, Elashoff R, Essner R, Glass EC, et al. Sentinel node biopsy for early-stage melanoma. Accuracy and morbidity in MSLT-1, an international multicenter trial. Ann Surg 2005;242:302-313.

  35. Khurana VG, Mentis DH, O’Brien CJ, Hurst TL, Stevens GN, Packham NA. Parotid and neck metastases from cutaneous squamous carcinoma of the head and neck. Am J Surg 1995;170:446-450.

  36. Tavin E, Persky M. Metastatic cutaneous squamous cell carcinoma of the head and neck region. Laryngoscope 1996;106:156-158.

  37. del Charco JO, Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Mendenhall NP. Carcinoma of the skin metastatic to the parotid area lymph nodes. Head Neck 1998;20:369-373.

  38. Lai SY, Weinstein GS, Chalian AA, Rosenthal DI, Weber RS. Parotidectomy in the treatment of aggressive cutaneous malignancies. Arch Otolaryngol Head Neck Surg 2002; 128:521-526.

  39. Eastman A, Erdman W, Lindberg M, Hunt J, Purdue G. Sentinel lymph node biopsy identifies occult nodal metastases in patients with Marjolin’s ulcer. J Burn Care Rehabil 2004;25:241-245.

  40. Michl C, Starz H, Bachter D, Balda RR. Sentinel lymphonodectomy in nonmelanoma skin malignancies. Br J Dermatol 2003;149:763-769.

  41. Nouri K, Rivas MP, Pedrosa F, Bhatia R, Civantos F. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck. Arch Dermatol 2004; 140:1284.

  42. Renzi C, Caggiati A, Mannooranparampil TJ, Passarelli F, Tartaglione G, Pannasilico GM, et al. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: Case series and review of the literature. EJSO (2006),doi:10.1016/j.ejso.2006.10.017.

  43. Gallegos JF, Labastida S, Castillo V, Barroso B, Reséndiz JA, Granados F. Mapeo linfático y biopsia del ganglio centinela en melanoma cutáneo. Informe preliminar. Rev Ins Nac Cancerol 1998;44:134-137.




2020     |     www.medigraphic.com